Trials / Withdrawn
WithdrawnNCT02857608
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Cardinal Health 414, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, open-label, within-subject, multi-center pilot study of Lymphoseek in the detection of lymph nodes in subjects with known squamous cell carcinoma of the anus.
Detailed description
Prospective, open-label, within-subject, multi-center pilot study of Lymphoseek in the detection of lymph nodes in subjects with known squamous cell carcinoma of the anus. All subjects will receive a single dose of 50 µg Lymphoseek radiolabeled with 0.5 millicurie (mCi) (18.5 MBq) 99mTc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lymphoseek |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-08-05
- Last updated
- 2017-03-15
Source: ClinicalTrials.gov record NCT02857608. Inclusion in this directory is not an endorsement.